Switzerland · Biotechnology startup
Switzerland · Monte Rosa Therapeutics
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Funding reportedLast round: Post ipo equity
What company datasets say Monte Rosa Therapeutics raised
Funding, as reported
Reported in all348.5Min the source's currency
Rounds5
Last roundPost ipo equity
Last round dateMay 2024
Investors listed14
Founders and team
From Monte Rosa Therapeutics's own website: 7 on the team.
- Markus WarmuthChief Executive Officer
- Filip JankuChief Medical Officer
- Jennifer ChampouxChief Operating Officer
- John CastleChief Data and Information Officer
- Magnus WalterChief Technology Officer
- Phil NicksonChief Business and Legal Officer
- Sharon TownsonChief Scientific Officer
AdvisersChandra P. Leo
Biotechnology in Switzerland
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Monte Rosa Therapeutics in front of investors. Or tell us what we have wrong.